ScatheZombie
Member
Yeah, I'm sure these companies being told what they're allowed to charge for a product (and in the process cutting their profit margins to shreds) - would be great news to them.
That's not how it will actually work. The number of companies that make mega-bucks by jacking up prices on existing patented medicines is incredibly small. The rest of the pharma industry wants them gone just as much as we do. Because everyone else is investing millions of dollars into R&D to make new drugs and charge mega-bucks for them. These other companies are weaseling their way into existing patents and exploiting the system.
In all likelihood, big pharma would actually support this type of legislation. Especially international pharma companies who may end up having an easier time importing their products from EU to the US market.
She can be a corporate shill and still pass legislation that helps us normal folks out at the same time - as long as it ultimately helps both sides - which this seemingly does.